Company Summary - Mediwatch PLC (LSE:MDW)
2.50p
0.00p
FTSE AIM All Share Health Care Equipment & ServicesMarket cap: £3.522m
NEW Explore our new and improved report for Mediwatch PLC >>
Gain access to various premium features such as detailed information on financial reports, broker forecasts, directors and shareholders information.
Summary
Development of medical devices used in the diagnosis of urological disorders
| Financials - Prelim (1/2/2012) | ||
|---|---|---|
| Turnover | £m | 10.59 |
| Pre-tax Profit | £m | 0.32 |
| EPS | p | 0.22 |
| DPS | p | 0.00 |
| Director | Board Role |
|---|---|
| Omer Karim | Chairman |
| Philip Stimpson | Chief Executive |
| Colm Croskery | Finance Director |
Products Brands & Subsidiaries
Products & Brands
BioScan & PSAwatch; Sensic Evolution
Subsidiaries
Mediwatch Biomedical Ltd; Medi-Watch UK Ltd; MediWatch USA Inc
Broker Sentiment (0 brokers)
No current consensus recommendation available.
| Heading | Date |
|---|---|
| Final Results | 01/02/2012 |
| Supply Agreement with NHS | 30/01/2012 |
| Notice of Final Results & Trading U... | 27/01/2012 |